Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariela Benigni

Showing results (51-60 of 228) with videos related to

Pageof 23
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2024
Tissue-Resident Macrophages in Solid Organ Transplantation: Harmful or Protective?Sistiana Aiello, Ariela Benigni, Giuseppe Remuzzi
Canadian Journal of Physiology and Pharmacology|September 12, 2008
Forefronts in endothelinPedro D'Orleans-Juste, Donald Kohan, Ariela Benigni
Pediatric Nephrology (Berlin, Germany)|March 19, 2020
Endothelin-targeted new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibitionAriela Benigni, Simona Buelli, Donald E Kohan
Kidney International|September 24, 2018
A new BEACON of hope for the treatment of inflammation? The endogenous metabolite itaconate as an alternative activator of the KEAP1-Nrf2 systemLuca Perico, Christina M Wyatt, Ariela Benigni
Nature Clinical Practice. Nephrology|March 28, 2008
Primer: strategies for identifying genes involved in renal diseaseMartin H de Borst, Ariela Benigni, Giuseppe Remuzzi
Cell Transplantation|July 11, 2006
The regenerative potential of stem cells in acute renal failureMarina Morigi, Ariela Benigni, Giuseppe Remuzzi, et al.
Stem Cell Research|November 7, 2018
Generation of two isogenic iPS cell lines (IRFMNi002-A and IRFMNi002-B) from a patient affected by Focal Segmental Glomerulosclerosis carrying a heterozygous c.565G>A mutation in PAX2 geneOsele Ciampi, Elena Romano, Ariela Benigni, et al.
Trends in Molecular Medicine|February 21, 2025
Is there a place for engineered immune cell therapies in autoimmune diseases?Luca Perico, Federica Casiraghi, Ariela Benigni, et al.
Pharmacological Research|April 21, 2016
Inhibiting angiotensin-converting enzyme promotes renal repair by modulating progenitor cell activationPaola Rizzo, Rubina Novelli, Ariela Benigni, et al.
International Journal of Molecular Sciences|February 15, 2022
Imaging the Kidney with an Unconventional Scanning Electron Microscopy Technique: Analysis of the Subpodocyte Space in Diabetic MiceSara Conti, Giuseppe Remuzzi, Ariela Benigni, et al.
Pageof 23

Showing results (51-60 of 228) with videos related to

Sort By:
Pageof 23
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2024
Tissue-Resident Macrophages in Solid Organ Transplantation: Harmful or Protective?Sistiana Aiello, Ariela Benigni, Giuseppe Remuzzi
Canadian Journal of Physiology and Pharmacology|September 12, 2008
Forefronts in endothelinPedro D'Orleans-Juste, Donald Kohan, Ariela Benigni
Pediatric Nephrology (Berlin, Germany)|March 19, 2020
Endothelin-targeted new treatments for proteinuric and inflammatory glomerular diseases: focus on the added value to anti-renin-angiotensin system inhibitionAriela Benigni, Simona Buelli, Donald E Kohan
Kidney International|September 24, 2018
A new BEACON of hope for the treatment of inflammation? The endogenous metabolite itaconate as an alternative activator of the KEAP1-Nrf2 systemLuca Perico, Christina M Wyatt, Ariela Benigni
Nature Clinical Practice. Nephrology|March 28, 2008
Primer: strategies for identifying genes involved in renal diseaseMartin H de Borst, Ariela Benigni, Giuseppe Remuzzi
Cell Transplantation|July 11, 2006
The regenerative potential of stem cells in acute renal failureMarina Morigi, Ariela Benigni, Giuseppe Remuzzi, et al.
Stem Cell Research|November 7, 2018
Generation of two isogenic iPS cell lines (IRFMNi002-A and IRFMNi002-B) from a patient affected by Focal Segmental Glomerulosclerosis carrying a heterozygous c.565G>A mutation in PAX2 geneOsele Ciampi, Elena Romano, Ariela Benigni, et al.
Trends in Molecular Medicine|February 21, 2025
Is there a place for engineered immune cell therapies in autoimmune diseases?Luca Perico, Federica Casiraghi, Ariela Benigni, et al.
Pharmacological Research|April 21, 2016
Inhibiting angiotensin-converting enzyme promotes renal repair by modulating progenitor cell activationPaola Rizzo, Rubina Novelli, Ariela Benigni, et al.
International Journal of Molecular Sciences|February 15, 2022
Imaging the Kidney with an Unconventional Scanning Electron Microscopy Technique: Analysis of the Subpodocyte Space in Diabetic MiceSara Conti, Giuseppe Remuzzi, Ariela Benigni, et al.
Pageof 23